Overexpression of thromboxane receptors and thromboxane synthase (TXS) has been reported in various types of cancers including colorectal, prostate, bladder, papillary thyroid and non-small-cell lung carcinomas [48,49,50,51,52]. Here, TBXAS1 is linked to cancer.